Bloomberg Asahi Kasei Corp is buying Denmark’s Veloxis Pharmaceuticals A/S for 143.2 billion yen ($1.3 billion), the companies said, in the latest of a series of deals by Japanese drugmakers. Asahi Kasei is offering to buy the ordinary shares and warrants of Veloxis for 6 kroner per share in a tender starting next month, they said in a statement. That’s ...

Bloomberg HP Inc rejected Xerox Holdings Corp’s request to open its financial books after turning down its unsolicited merger offer last week, saying that the smaller suitor hasn’t proven it’s healthy enough to raise the funding or complete such a transaction. “Your proposal does not constitute a basis for due diligence or negotiation,” Chief Executive Officer Enrique Lores and Chairman ...

Bloomberg Novartis AG agreed to buy Medicines Co and its promising heart drug for $9.7 billion, the latest move in the Swiss drugmaker’s push to amass novel treatments for complex conditions. Medicines Co’s experimental treatment inclisiran uses a new approach to lower bad cholesterol in especially hard-to-treat patients. Novartis Chief Executive Officer Vas Narasimhan was willing to foot the bill, ...